Skip to content

A study on the impact of Staged Continuity of Care on Scar Management and Satisfaction in Patients Undergoing Residual flap shaping and suturing after Mastectomy

A study on the impact of Staged Continuity of Care on Scar Management and Satisfaction in Patients Undergoing Residual flap shaping and suturing after Mastectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116819
Enrollment
Unknown
Registered
2026-01-15
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

The intervention group:The intervention group received systematic, structured staged continuity of care for 6 months post-discharge in addition to standard perioperative care.
The control group:the control group received only routine care and discharge guidance

Sponsors

Chengdu Shang Jin Nan Fu Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age and gender: Female, aged between 18 and 75 years. 2. Disease diagnosis: Pathologically confirmed breast cancer, undergoing modified radical mastectomy with residual skin flap shaping and suture. 3. Postoperative condition: Postoperatively stable general condition with vital signs within normal limits, absence of severe organ dysfunction, and ability to cooperate with nursing assessments and follow-up. 4. Cognitive and linguistic abilities: No language barriers or major cognitive impairment, capable of independently understanding and completing relevant scales. 5. Informed consent: Voluntarily participated in the study and provided written informed consent.

Exclusion criteria

Exclusion criteria: 1.Other malignant tumors or distant metastasis: Presence of other malignant tumors or postoperative distant metastasis with an expected survival of less than 6 months. 2.Severe postoperative complications: Severe complications in the early postoperative period, such as flap necrosis, severe infection, hematoma, or wound dehiscence, which could interfere with the implementation of nursing interventions. 3.Mental illness or cognitive impairment: Comorbid psychiatric disorders or cognitive impairment rendering the patient unable to cooperate with scale assessments or interviews. 4.Participation in other clinical trials: Concurrent participation in other clinical trials that could affect postoperative recovery or scar management.

Design outcomes

Primary

MeasureTime frame
Vancouver Scar Scale (VSS);The Chinese version of the Functional Assessment of Cancer Therapy–Breast (FACT-B);a self-designed Continuity of Care sever Satisfaction Questionnaire;The Chinese version of the Hospital Anxiety and Depression Scale (HADS);Body Image Scale,BIS;

Secondary

MeasureTime frame
the incidence of common complications within 30 days after surgery ;tracking readmissions and outpatient revisits related to the surgical site within 6 months postoperativel;

Countries

China

Contacts

Public ContactXuezhen Hu

Chengdu Shang Jin Nan Fu Hospital

1373830145@qq.com+86 173 8068 6107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026